NCT00560586View on ClinicalTrials.gov

Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

May 31, 2006

Study Completion Date

August 31, 2007

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Budesonide

1 puff each nostril (32 micrograms) at bedtime

DRUG

placebo

1 puff each nostril at bedtime

Trial Locations (1)

40202

Kosair Children's Hospital Sleep Center, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT00560586 - Nasal Budesonide in Children With Rhinitis and/or Mild Obstructive Sleep Apnea Syndrome | Biotech Hunter | Biotech Hunter